| Today's Open | $18.80 |
|---|---|
| Previous Close | $18.85 |
| Daily Range | $18.80 - $18.96 |
| 52-Week Range | $14.41 - $27.25 |
| Market Cap | $1.3B |
| P/E Ratio | 8.61 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 488,747 |
| Average Daily Volume | 1,238,954 |
| Current FY EPS | $0.16 |
Sector
Healthcare
Industry
Drugs
Impax Laboratories Inc. (IPXL) Description
Impax Laboratories Inc. is a technology-based specialty pharmaceutical company focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals utilizing its controlled-release and other in-house development. Website: http://www.impaxlabs.com/
News & Commentary
Does Restless Legs Syndrome Really Shorten Life Span?
A new study suggests a link between this neurological disorder and mortality rates in men.
Around 110 workers will be relieved of their positions.
Clinical Trial Disappointment for This Pharmaceutical Giant
What does this mean for Merck going forward?IPXL's Top Competitors
(0.00%)
(-0.23%)
(0.82%)
(0.85%)